Professor Martin Stockler is Director of Cancer Trials at the CTC, and Professor of Cancer Medicine and Clinical Epidemiology at the Sydney Medical School, University of Sydney.

After internal medicine training at the Prince of Wales and Prince Henry Hospitals, and medical oncology training at the Royal Prince Alfred Hospital, also in Sydney, he spent three years in Canada doing a clinical research fellowship at the Princess Margaret Hospital and a Masters in Clinical Epidemiology at the University of Toronto.

Martin's research focuses on improving quality of life, survival, prognostication, and doctor-patient communication for those affected by cancer, particularly those arising from genitourinary, breast, gynaecologic, and lung primaries. His clinical focus is genitourinary cancer.

The first protocol he wrote was for a randomised trial incorporating quality of life assessment in routine clinical practice; alas, the trial never happened. His first successful protocol was for a small (tiny), placebo-controlled, crossover trial of paracetamol (acetaminophen) for people with advanced cancer and troublesome pain despite a strong opioid regimen (J Clin Oncol 2004: 22; 3389).

Research interests

• Improving quality of life and survival
• Prognostication and doctor-patient communication for those affected by cancer, particularly genitourinary (prostate, testis, kidney, bladder), gynaecologic (ovary, endometrium, cervix), and thoracic (lung and mesothelioma)
• Clinical trials
• Meta-analaysis
• Evidence based medicine
• Biostatistics

Teaching and supervision

Oncology, clinical research methods, evidence-based medicine, patient-doctor communication.

Publications

View Martin's publications.